This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Bayer sues Glenmark over generic Finacea


Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of rosacea treatment Finacea.

Bayer, Finacea, Intendis, Intraserv, generic, USPTO, patent extension


Payment types accepted